Are peptides steroids? The chemistry and the law behind the question

No. A peptide is a chain of amino acids joined by amide bonds; a steroid is a lipid built on a four-ring carbon skeleton. Why the two are made, regulated and listed differently, with a comparison table.

By Touchstone PeptidesSeptember 22, 20269 minute read

No. A peptide is a chain of amino acids joined end to end by amide bonds; a steroid is a lipid built on a rigid four-ring carbon skeleton. They are made by different chemistry, they are handled by different US statutes (anabolic steroids are Schedule III controlled substances; peptides sold for research are not scheduled at all, but become unapproved new drugs the moment they are intended for human use), and the World Anti-Doping Agency lists them in different sections. "Peptide hormones" on the WADA list is a category name, not a claim of chemical kinship with steroids. Statuses below are as of September 21, 2026.

What a peptide is, chemically

The IUPAC-IUB nomenclature recommendations define the class in one sentence: "A peptide is any compound produced by amide formation between a carboxyl group of one amino acid and an amino group of another." Each amino acid that has been joined is called an amino-acid residue, "The amide bonds in peptides may be called peptide bonds", and sequences are written with the N-terminal residue on the left. The same document draws the size line loosely: "Peptides with fewer than about 10-20 residues may also be called oligopeptides; those with more, polypeptides."

So a peptide is defined by a repeating backbone, nitrogen-carbon-carbon, nitrogen-carbon-carbon, with a side chain on every second carbon. BPC-157, fifteen residues, has the formula C62H98N16O22 and a molecular weight of 1419.5 according to PubChem. Sixteen nitrogen atoms in the formula is the signature of a chain of amide bonds. The existing piece on what a peptide is covers the backbone in more detail.

What a steroid is, chemically

The IUPAC-IUB recommendations on steroid nomenclature define the class by its skeleton: "Steroids are compounds possessing the skeleton of cyclopenta[a]phenanthrene or a skeleton derived therefrom by one or more bond scissions or ring expansions or contractions." That skeleton is three six-membered rings and one five-membered ring fused together, lettered A to D and numbered by convention. Testosterone, the reference compound in the US legal definition of an anabolic steroid, has the formula C19H28O2 and a molecular weight of 288.4; PubChem's systematic name for it ends in "cyclopenta[a]phenanthren-3-one", which is the skeleton with the ring system spelled out.

A steroid, then, is a small, mostly hydrocarbon molecule with no amide bonds, no nitrogen in the parent skeleton and no sequence. Its variations are substituents and double bonds on a ring system that is the same across the whole class. Two features follow. Steroids are lipids, which is why they are poorly soluble in water and why the natural ones are carried in blood on binding proteins. And they cannot be "read" residue by residue, because there is nothing repeating to read.

How each is made

A synthetic peptide is assembled one residue at a time on a solid resin, each amino acid added with its reactive groups protected, then cleaved, purified by reversed-phase HPLC and freeze-dried. That process is described in why a forty-residue peptide costs what it does. The starting materials are the twenty proteinogenic amino acids and a catalog of non-natural ones; the product is a sequence.

A steroid is made by ring chemistry. Industrially, most steroid drugs are prepared by multi-step organic synthesis or semi-synthesis starting from a steroid already possessing the ring system, with the target molecule reached by adding, removing or rearranging substituents. There is no chain to elongate and no sequence to check; identity is established from the substitution pattern on the rings.

The difference shows up on paperwork. A peptide certificate carries a mass-spectrometry identity against a calculated mass and an HPLC purity that reflects deletion and modification sequences; a steroid certificate carries identity by spectroscopy against a reference standard and purity against ring-isomer impurities. The two documents are not comparable line by line.

Why the law handles them differently

Anabolic steroids are controlled substances. The Controlled Substances Act defines the term at 21 U.S.C. 802(41)(A) as "any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone)", followed by an enumerated list of compounds and a closing clause covering "any salt, ester, or ether of a drug or substance described in this paragraph". Paragraph (41) was added by the Anabolic Steroids Control Act of 1990 (Pub. L. 101-647), rewritten by the Anabolic Steroid Control Act of 2004 (Pub. L. 108-358, October 22, 2004), and extended by the Designer Anabolic Steroid Control Act of 2014 (Pub. L. 113-260, December 18, 2014), which added subparagraph (C) to capture unlisted substances:

a drug or hormonal substance (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that is not listed in subparagraph (A) and is derived from, or has a chemical structure substantially similar to, 1 or more anabolic steroids listed in subparagraph (A) shall be considered to be an anabolic steroid for purposes of this chapter if ... the drug or substance has been created or manufactured with the intent of producing a drug or other substance that either ... promotes muscle growth; or ... otherwise causes a pharmacological effect similar to that of testosterone21 U.S.C. 802(41)(C), as added by Pub. L. 113-260

Anabolic steroids sit in Schedule III, listed at section 812(c) Schedule III(e) and in 21 CFR 1308.13(f), which places in the schedule "any substance meeting the definition of anabolic steroid as set forth in § 1300.01 of this chapter, including any material, compound, mixture or preparation containing any quantity of the following substances", followed by the enumerated list. Schedule III is defined by three statutory findings, in the statute's own words:

(A) The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. (B) The drug or other substance has a currently accepted medical use in treatment in the United States. (C) Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.21 U.S.C. 812(b)(3)

Manufacture, distribution and possession are governed by DEA registration and the CSA's penalties. The 2014 Act also requires that anabolic steroid labels use IUPAC nomenclature, which is a labelling rule specific to this class.

Peptides are not scheduled. The definition in 802(41) is anchored to the testosterone ring system, and a peptide cannot be "chemically and pharmacologically related to testosterone" in the sense of subparagraph (A) or "derived from" a listed steroid in the sense of subparagraph (C). No peptide appears in Schedule III(e) or in 21 CFR 1308.13(f), and neither human growth hormone nor chorionic gonadotropin appears in the five schedules of section 812(c). A research peptide is therefore not a controlled substance under federal law.

What governs peptides instead is the Federal Food, Drug, and Cosmetic Act. Under that Act a peptide becomes a drug when it is intended for use in a person, and an unapproved new drug cannot lawfully enter interstate commerce; intent is judged from the seller's claims and the circumstances of distribution, not from a disclaimer, which is why this site publishes no claims and no use guidance. The statute and FDA's reading of it are set out in are peptides legal in the United States and what "research use only" actually means.

The practical difference: a vial of an anabolic steroid is unlawful to possess without a prescription under the CSA regardless of what the label says. A vial of a research peptide is not a controlled substance; its lawfulness turns on what it is intended for, which is a question about the seller's claims and the circumstances of its distribution.

"Peptide hormones" is a WADA category, not a chemical kinship

The WADA Prohibited List keeps the two classes apart. Section S1, Anabolic Agents, opens "Anabolic agents are prohibited." Its first subsection, "S1.1. ANABOLIC ANDROGENIC STEROIDS (AAS)", is a list of ring compounds "and other substances with a similar chemical structure or similar biological effect(s) including their esters"; S1.2, "OTHER ANABOLIC AGENTS", adds clenbuterol, SARMs and similar non-steroid molecules. Section S2 is "Peptide Hormones, Growth Factors, Related Substances, and Mimetics", and its examples are peptides and proteins: growth hormone and its analogues, "growth hormone-releasing hormone (GHRH) and its analogues (e.g. CJC-1293, CJC-1295, sermorelin and tesamorelin)", growth hormone secretagogues such as ipamorelin, and "Thymosin-ß4 and its derivatives e.g. TB-500".

Both sections are prohibited at all times. But they are listed apart because they are different kinds of molecule, and being in S2 does not make a peptide a steroid any more than being in S1.2 makes clenbuterol one. BPC-157 is in neither: WADA names it in section S0, the catch-all for substances "with no current approval by any governmental regulatory health authority for human therapeutic use". Where each stocked peptide sits is set out in WADA S0, S2 and strict liability.

Two things WADA status does not do. It does not change US legal status: WADA is a sports body and its list has no force outside anti-doping rules. And it does not describe chemistry: "similar biological effect(s)" is the List's own criterion, and it deliberately ignores structure.

The comparison

	Peptide	Steroid
Building block	Amino acids	A four-ring carbon skeleton (cyclopenta[a]phenanthrene)
Bond that defines the class	Amide (peptide) bond between residues	Fused carbon rings; no amide backbone
Typical size	Two residues to several dozen; BPC-157 is 1419.5	Small; testosterone is 288.4
Nitrogen	One per residue in the backbone	None in the parent skeleton
Solubility character	Generally water-soluble, sequence-dependent	Lipid, poorly water-soluble
How it is made	Solid-phase synthesis, residue by residue	Multi-step organic or semi-synthesis on a ring system
Identity test on a certificate	Mass spectrometry against a calculated mass	Spectroscopy against a reference standard
US controlled-substance status (as of September 21, 2026)	Not scheduled	Anabolic steroids are Schedule III (21 U.S.C. 812; 21 CFR 1308.13(f))
Governing statute for a research vial	FD&C Act intended-use provisions (21 U.S.C. 321, 355)	Controlled Substances Act (21 U.S.C. 802(41)) plus the FD&C Act
WADA section	S2 for peptide hormones and releasing factors; S0 for unapproved substances such as BPC-157	S1.1

Is BPC-157 a steroid?

No. It is a fifteen-residue peptide, sequence GEPPPGKPADDAGLV, with no ring skeleton of any kind. It does not meet the definition in 21 U.S.C. 802(41), is not in Schedule III, and is named on the WADA list under S0 rather than S1; its drug status, dated, is in BPC-157 in 2026. The same is true in kind for the GHRH analogues and secretagogues on the hormones shelf, such as sermorelin, a twenty-nine-residue GHRH analogue, and ipamorelin, a pentapeptide: they are peptides listed under WADA S2.2.4, not steroids under S1.1, and they are not controlled substances. The question "is this peptide a steroid" has a chemical answer and a legal answer, and both are no.

Sources

For laboratory research use only. Not a drug, not a supplement, and nothing here is a claim about what any of this material does in a person or an animal.

Two things before you come in.